1. Home
  2. NTRA vs FCNCA Comparison

NTRA vs FCNCA Comparison

Compare NTRA & FCNCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$244.06

Market Cap

27.0B

Sector

Health Care

ML Signal

HOLD

Logo First Citizens BancShares Inc.

FCNCA

First Citizens BancShares Inc.

HOLD

Current Price

$1,975.46

Market Cap

22.6B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTRA
FCNCA
Founded
2003
1898
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
27.0B
22.6B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
NTRA
FCNCA
Price
$244.06
$1,975.46
Analyst Decision
Strong Buy
Buy
Analyst Count
16
10
Target Price
$227.69
$2,139.00
AVG Volume (30 Days)
1.7M
87.9K
Earning Date
11-06-2025
01-23-2026
Dividend Yield
N/A
0.43%
EPS Growth
N/A
N/A
EPS
N/A
169.29
Revenue
$2,116,676,000.00
$8,897,000,000.00
Revenue This Year
$32.77
$3.19
Revenue Next Year
$16.51
N/A
P/E Ratio
N/A
$11.65
Revenue Growth
38.17
N/A
52 Week Low
$125.38
$1,473.62
52 Week High
$245.59
$2,412.93

Technical Indicators

Market Signals
Indicator
NTRA
FCNCA
Relative Strength Index (RSI) 80.03 71.01
Support Level $233.67 $1,870.90
Resistance Level $240.18 $1,901.03
Average True Range (ATR) 7.39 40.29
MACD 0.68 12.43
Stochastic Oscillator 97.49 96.61

Price Performance

Historical Comparison
NTRA
FCNCA

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About FCNCA First Citizens BancShares Inc.

First Citizens BancShares Inc is the bank holding company of First Citizens Bank and Trust Company. The company's segments include the General Bank, the Commercial Bank, SVB Commercial, and Rail. The General Bank segment delivers products and services to consumers and businesses through its extensive network of branches and various digital channels. The Commercial Bank segment provides financial services, including lending, leasing, and advisory, to small and mid-market businesses across various industries. The SVB Commercial provides financial services to innovators, investors, and venture firms. The Rail segment provides tailored leasing and financing for railcars and locomotives across North America. It generates the majority of its revenue from the General Banking segment.

Share on Social Networks: